Ambry Genetics Research Highlights Need for Expanded Genetic Testing Payer Coverage for Patients At-Risk for Hereditary Breast and Ovarian Cancer

ALISO VIEJO, Calif. (PRWEB) May 02, 2019 Researchers from Ambry Genetics (Ambry), a leading clinical genetics testing company, will present results documenting discrepancies between U.S. insurer policies for genetic testing and the 2019 National Comprehensive Cancer Network (NCCN) medical m…

Source link

Related posts

Reply to “Far away from the lamppost”


Fight Aging! Newsletter, August 19th 2019


How does the water springtail optically locate proper habitats? Spectral sensitivity of photo- and polarotaxis in Podura aquatica [RESEARCH ARTICLE]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy